Chengzhong Wang

Dr. Wang is a Principal Scientist at Mitokinin. In that role, he is tasked with investigating the impact of PINK1 amplification on Parkinson’s disease pathobiology across numerous model systems, including human patient-derived iPSC neurons.

Dr. Wang brings over a decade of experience working in leading neuroscience labs to Mitokinin. He completed his Ph.D at the Institute for Neuroscience at the Chinese Academy of Sciences in Shanghai. He then completed his Postdoctoral training in the lab of Yadong Huang at the Gladstone Institutes UCSF), where he investigated apoE4 and tau in hiPSC models of Alzheimer’s disease. His work has been published in leading journals, including Nature Medicine, Cell Stem Cell, and Nature Cell Biology.